TORONTO–(BUSINESS WIRE)–Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that it will participate in the following investor conferences: Piper Sandler 37th Annual Healthcare Conference (New York, NY) Date: Wednesday, Dec. 3, 2025 Time: 12:50 p.m. ET Format: Presentation Webcast: Live webcast available with replay to follow on the Sa.
This excerpt is quoted from the original release. Read the full announcement on Business Wire.
Brief Summary
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) is set to participate in the upcoming investor conferences that could present significant opportunities for investors. The key details are as follows:
- Piper Sandler 37th Annual Healthcare Conference
- Date: Wednesday, Dec. 3, 2025
- Time: 12:50 p.m. ET
- Format: Live Presentation & Webcast
This conference offers investors a chance to gain insights into Satellos’ innovative approaches to tackling degenerative muscle diseases. Why it matters: Understanding these developments is crucial as they could influence the biotech sector significantly.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by Business Wire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.